Anti‐Friction MSCs Delivery System Improves the Therapy for Severe Osteoarthritis. Issue 52 (24th October 2021)
- Record Type:
- Journal Article
- Title:
- Anti‐Friction MSCs Delivery System Improves the Therapy for Severe Osteoarthritis. Issue 52 (24th October 2021)
- Main Title:
- Anti‐Friction MSCs Delivery System Improves the Therapy for Severe Osteoarthritis
- Authors:
- Yan, Xin
Yang, Bo
Chen, Yourong
Song, Yifan
Ye, Jing
Pan, Yufan
Zhou, Bini
Wang, Yuqing
Mao, Fengbiao
Dong, Yuanchen
Liu, Dongsheng
Yu, Jiakuo - Abstract:
- Abstract: Osteoarthritis (OA) is a musculoskeletal disorder disease affecting about 500 million people worldwide and mesenchymal sem cells (MSCs) therapy has been demonstrated as a potential strategy to treat OA. However, the shear forces during direct injection and the harsher shear condition of OA environments would lead to significant cell damage and inhibit the therapeutic efficacy. Herein, DNA supramolecular hydrogel has been applied as delivering material for MSCs to treat severe OA model, which perform extraordinary protection in MSCs against the shear force both in vitro and in vivo. It is demonstrated that the DNA supramolecular hydrogel can promote formation of quality cartilage, reduce osteophyte, and normalize subchondral bone under the high friction condition of OA, whose molecular mechanisms underlying therapeutic effects are also investigated. It can be anticipated that DNA supramolecular hydrogel would be a promising cell delivery system for multiple potential MSCs therapy. Abstract : A DNA supramolecular hydrogel is employed as a carrier for bone marrow mesenchymal stem cells (BMSCs) to treat osteoarthritis (OA). Compared with current clinical strategies, the DNA supramolecular hydrogel can significantly improve the vitality of BMSCs during delivery, and provide cells with long‐term antifriction protection, excellent permeability, 3D support, and 3D microenvironment of cell proliferation and differentiation, ultimately enhancing the therapeutic effect ofAbstract: Osteoarthritis (OA) is a musculoskeletal disorder disease affecting about 500 million people worldwide and mesenchymal sem cells (MSCs) therapy has been demonstrated as a potential strategy to treat OA. However, the shear forces during direct injection and the harsher shear condition of OA environments would lead to significant cell damage and inhibit the therapeutic efficacy. Herein, DNA supramolecular hydrogel has been applied as delivering material for MSCs to treat severe OA model, which perform extraordinary protection in MSCs against the shear force both in vitro and in vivo. It is demonstrated that the DNA supramolecular hydrogel can promote formation of quality cartilage, reduce osteophyte, and normalize subchondral bone under the high friction condition of OA, whose molecular mechanisms underlying therapeutic effects are also investigated. It can be anticipated that DNA supramolecular hydrogel would be a promising cell delivery system for multiple potential MSCs therapy. Abstract : A DNA supramolecular hydrogel is employed as a carrier for bone marrow mesenchymal stem cells (BMSCs) to treat osteoarthritis (OA). Compared with current clinical strategies, the DNA supramolecular hydrogel can significantly improve the vitality of BMSCs during delivery, and provide cells with long‐term antifriction protection, excellent permeability, 3D support, and 3D microenvironment of cell proliferation and differentiation, ultimately enhancing the therapeutic effect of BMSCs. … (more)
- Is Part Of:
- Advanced materials. Volume 33:Issue 52(2021)
- Journal:
- Advanced materials
- Issue:
- Volume 33:Issue 52(2021)
- Issue Display:
- Volume 33, Issue 52 (2021)
- Year:
- 2021
- Volume:
- 33
- Issue:
- 52
- Issue Sort Value:
- 2021-0033-0052-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-10-24
- Subjects:
- cartilage repair -- cell therapy -- DNA supramolecular hydrogels -- mesenchymal stem cells -- osteoarthritis
Materials -- Periodicals
Chemical vapor deposition -- Periodicals
620.11 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4095 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/adma.202104758 ↗
- Languages:
- English
- ISSNs:
- 0935-9648
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0696.897800
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 27010.xml